FDA inspection
Zhejiang Tiantai Pharmaceutical Co., Ltd. (Cangshan Plant): FDA inspection ending Mar 24, 2016
FDA inspection 972159 · No Action Indicated (NAI) · Taizhou
Key facts
| Inspection ID | 972159 |
|---|---|
| Firm | Zhejiang Tiantai Pharmaceutical Co., Ltd. (Cangshan Plant) |
| FEI number | 3031056375 |
| Address | No. 588 Fengzelu, Tiantaixian |
| City | Taizhou |
| Country | China |
| Fiscal year | 2016 |
| Inspection end date | Mar 24, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data